RJF RAYMOND JAMES FINANCIAL INC Insider Trading

CAO Allaire Bella Loykhter sold 29,551 shares of RJF at $142.34; stock now down -10.8% in 30 days

Allaire Bella Loykhter, Chief Admin Officer, sold 29,551 shares (29.6K shares) of RAYMOND JAMES FINANCIAL INC (RJF) at $142.34 on 2026-03-19 for $4,206,289.34 ($4.2M), reducing holdings from 83,137 shares (83.1K shares) to 53,586 shares (53.6K shares), a -35.5% reduction in position size. The sale occurred at $142.34, and RJF has since declined to $143.81 current price, down -10.8% over 30 days and -11.8% over 90 days from the transaction date. Loykhter's prior open-market sell at RJF on 2024-07-31 posted a 90-day return of +29.6%, indicating the stock rose after that prior sale—poorly-timed from an insider sales perspective. The company's fundamentals remain solid with P/E of 13.52, annual revenue growth of +9.7%, and market cap of $28,343,662,030.97 ($28.3B). The current sale removes a substantial portion of her position and occurs amid a period of stock weakness, though the timing pattern offers no clear predictive signal relative to her historical outcomes at this ticker.

EVP Jonathan N Santelli sells 4,500 RJF shares at $170.46; retains 26,853 shares post-sale.

Jonathan N Santelli, EVP and General Counsel at Raymond James Financial, sold 4,500 shares at $170.46 on 2026-02-04, reducing his holdings from 31,353 shares to 26,853 shares. The sale occurred near the 52-week high of $176.43, with the stock currently trading at $167.44. Santelli retains substantial holdings of 26,853 shares post-transaction, indicating continued material financial interest in the company. The transaction represents a -14.4% reduction in his shareholdings but does not suggest a dramatic shift in confidence given the executive maintains a significant ownership position in a company posting strong fundamentals (9.7% annual revenue growth, 14.96 P/E, $436.0M net income on $3.4B revenue).

Executive Chair Paul C Reilly sold 130,687 shares for $21,321,441.58 at Raymond James on 2025-12-15

Paul C Reilly, Executive Chair at Raymond James Financial, executed 3 separate sales totaling 130,687 shares for $21,321,441.58 at a blended average price of $163.15, reducing his holdings by -33.4% from 391,233 to 260,546 shares. The timing of this significant stake reduction—at prices near the 52-week range of $123.65–$176.43—follows a pattern consistent with prior same-ticker sales: his previous sell on 2024-12-02 generated a 90d return of -7.6%, indicating it was well-timed, while his 2023-11-29 sale saw a 90d return of +15.1%, indicating it was poorly timed. The current price of $162.83 sits -7.7% from the 52-week high, and the blended transaction prices of $163.15 represent execution near recent highs. This large divestiture of a substantial portion of his holdings is material and merits close observation of the underlying business fundamentals and any concurrent company disclosures.

RJF: Tashtego sells 10,000 shares at $159.46; retains 34,497 shares. P/E 14.69, stock -5.7% from 52-week high.

Elwyn Tashtego, President of PCG, sold 10,000 shares (10.0K shares) at $159.46 on 2024-12-13 in an open-market transaction, reducing his position by 22.5%. His prior sale at RJF on 2024-08-12 posted a 90-day return of +44.8%, indicating the stock rose substantially after that sale—a poorly-timed outcome for the insider. Raymond James Financial trades at a P/E of 14.69 with recently posted revenue of $3,228,000,000.00 ($3.2B) and annual growth of +10.4%, placing the company in a stable but not exceptional valuation context. The current price of $160.41 is down 5.7% from the 52-week high of $170.10, though up 32.9% over the past 90 days, suggesting recent strength in the name even after this sale.

RJF President Carter Horace sells 5,000 shares at $165.03 in second reduction; retains 34,603 post-trade.

Carter Horace, President of Fixed Income, executed a sale of 5,000 shares at $165.03, reducing his holdings from 39,603 to 34,603 shares, a -12.6% decrease. This transaction reflects an open-market sale by a senior executive at a stock trading near its 52-week highs ($165.54 current vs. $170.10 52-week high). The company's fundamentals remain solid with $3.2B in quarterly revenue, $492.0M net income, 10.4% annual revenue growth, and a 15.16 P/E ratio. While the executive retains meaningful holdings, the sale at an elevated price point merits monitoring to determine if this represents a pattern or isolated liquidation.

RJF Executive Chair Raney Steven M sells 13,845 shares in 3 transactions at blended avg $169.02 for $2.3M, reducing holdings 24.2%

Raney Steven M executed 3 separate sales totaling 13,845 shares for $2,340,134.54 on November 29 and December 2, 2024, at prices ranging from $167.39 to $170.10, representing a 24.2% reduction in his holdings from 57,277 shares to 43,432 shares. The sales occurred near Raymond James Financial's 52-week high of $170.10, with the blended average price of $169.02 only 2.1% below the peak. Across his open-market history (all tickers), Raney's prior 2 sells achieved a 90d well-timed rate of 50.00%, and his same-ticker history at RJF shows 1 of 2 prior sells were well-timed; the most recent sale at this ticker on 2024-04-26 had a positive 30d return (+4.0%) but negative 90d return (-2.5%). The company reports strong fundamentals with $3.2B quarterly revenue, +10.4% annual growth, and a moderate P/E of 15.15, though the 30-day price momentum (+14.7%) and 90-day gain (+38.9%) reflect sharp recent appreciation into which these sales were executed.

RJF Chair & CEO Paul Reilly sold 50,000 shares for $8.4M on 2024-12-02; stock at $165.45 now, -2.7% from 52-week high.

Paul Reilly, Chair & CEO of Raymond James Financial, sold 50,000 shares at $167.30 on 2024-12-02, reducing his holdings by 15.0% from 333,110 to 283,110 shares. The sale occurred near the 52-week high (within 2.7% of the $170.10 peak) in a context where the stock has delivered strong recent returns: +14.7% over the prior 30 days and +38.9% over 90 days. Across his cross-ticker track record, Reilly's prior 1 sell resulted in a +15.1% 90-day return, meaning the stock rose after his sale — a poorly-timed exit. His same-ticker RJF sale one year prior (2023-11-29) also delivered +15.1% over 90 days, establishing a pattern of sales that preceded continued gains. The company's fundamentals remain solid with revenue of $3,228,000,000.00 and net income of $492,000,000.00 in the latest quarter, along with 10.4% annual revenue growth and a 15.15 P/E ratio.

RJF CEO Tashtego sells 31,277 shares for $3.4M; holdings cut 46.9% to 35,380 shares

On 2024-08-12, Elwyn Tashtego, CEO & President of Raymond James Financial, sold 31,277 shares at $109.64, reducing his holdings by 46.9% from 66,657 shares to 35,380 shares. The sale occurred when RJF was trading below its 52-week high of $129.99 (current price $111.79 is -14.0% from that peak) and at a material discount to where the stock traded 90 days prior (price down 12.2% over that period). The company fundamentals remain solid with $3.2B in quarterly revenue, $492.0M net income, and a P/E of 12.11, providing context that this is not a distressed-company exit. The substantial reduction in the CEO's personal stake—disposing of nearly half his holdings—represents a material change in his direct economic exposure to the company, which merits investor attention to any forward-looking company guidance or strategic positioning changes.

EVP Allaire Bella Loykhter sold 17,363 shares of RJF at $115.00 (31-Jul-2024); stock now down 9.7% in 30 days

Allaire Bella Loykhter, Executive Vice President at Raymond James Financial, sold 17,363 shares at $115.00 on July 31, 2024, reducing her holdings by 18.7% from 92,949 to 75,586 shares. The transaction occurred at a price $6.00 above the current market price of $109.00, and the stock has declined 9.7% over the subsequent 30 days and 12.4% over 90 days. Raymond James fundamentals remain stable with a 12.72 P/E and 5.6% annual revenue growth, though the stock is currently 16.2% below its 52-week high. The sale represents a material reduction in an executive's direct holdings in a company with $22.6B market capitalization.